SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 301 filers reported holding SEATTLE GENETICS INC in Q2 2017. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $23,000 | +43.8% | 300 | 0.0% | 0.01% | +25.0% |
| Q1 2018 | $16,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $16,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $16,000 | -48.4% | 300 | -50.0% | 0.00% | -55.6% |
| Q2 2017 | $31,000 | -3.1% | 600 | 0.0% | 0.01% | -10.0% |
| Q1 2017 | $32,000 | 0.0% | 600 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $32,000 | -25.6% | 600 | -25.0% | 0.01% | -28.6% |
| Q3 2016 | $43,000 | +34.4% | 800 | 0.0% | 0.01% | +27.3% |
| Q2 2016 | $32,000 | +14.3% | 800 | 0.0% | 0.01% | -8.3% |
| Q1 2016 | $28,000 | -22.2% | 800 | 0.0% | 0.01% | -63.6% |
| Q4 2015 | $36,000 | -7.7% | 800 | -20.0% | 0.03% | +73.7% |
| Q3 2015 | $39,000 | – | 1,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
| Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
| Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
| DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
| Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
| Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
| EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
| CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |